Financials
- Market Capitalization 2.46 B
- Employee 47
- Founded 1998
- CEO Helen Sabzevari
- Website www.precigen.com
- Headquarter Virginia, United States
- FIGI BBG000QL8VH9
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 1863 | BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 9.59 USD | -2.34% | -1.03% | +6.56% | +14.58% | 2.45 B USD | ||
| 1864 | VERA Vera Therapeutics, Inc. - Class A Common Stock | 33.65 USD | -1.58% | -1.23% | +5.75% | +13.15% | 2.42 B USD | ||
| 1880 | TRVI Trevi Therapeutics, Inc. - Common Stock | 16.29 USD | -2.98% | -7.76% | -11.13% | +127.83% | 2.32 B USD | ||
| 1893 | KOD Kodiak Sciences Inc - Common Stock | 37.09 USD | -1.67% | -1.77% | -10.80% | +319.10% | 2.33 B USD |